Lifeboat Foundation

Northrop Grumman built DARPA’s experimental R3D2 satellite in record time, the company says.

Note: This post is being updated and is under construction for May 12. Thanks for your patience!

IMAGE

— contents.

Continue reading “Digest note: This post is being updated and is under construction for May 12” »

Club for the Future is for you, the dreamers of tomorrow.

Club members’ ideas combined with a foundation of affordable, frequent, and reliable access to space, will help spark a future without limits. Dream. Experiment. Build. As we grow, look out for new activities, content, and opportunities to access space.

A remote-controlled ship carrying British oysters to Belgium becomes the first cargo vessel in the world to traverse the seas without a crew…

A boat carrying a cargo of British oysters across the English Channel has become the world’s first ever shipment completed using remote control.

Continue reading “Ship carrying oysters is world’s first remote-controlled cargo trip” »

A seven-mile “bee corridor” of vibrant wildflowers is being planted to encourage the insect’s population in London. The pathway for bees will be formed of 22 meadows sown through parks and green spaces in the north west of the capital. These will be in place in time for summer according to Brent council, which says it hopes the move will halt the decline in biodiversity in the borough.

Yes, wasps are terrifying, we know that. But now, according to new research, we know that they’re not just terrifying, they’re also smart.

O.o…

A group of Danish innovators have launched a kickstarter campaign for underpants that don’t need to be washed with every use.

Flow batteries, an emerging technology, could be more durable and hardy than the most popular grid-scale batteries in use today. Now, California’s independent system operator has hooked one up.

Newly identified subsets of cell types present in joint tissue in people with rheumatoid arthritis and how they interact may explain why only some people respond to existing medications, according to two studies by co-senior author Laura Donlin, Ph.D., Co-Director of the Derfner Foundation Precision Medicine Laboratory at Hospital for Special Surgery (HSS) and collaborating colleagues. The findings suggest exciting new targets for developing precision medicine strategies in the future.

Rheumatoid arthritis (RA) is an autoimmune disease that affects the joints. The immune system mistakenly perceives joint tissue as a harmful invader, like a bacteria or virus, and attacks it, causing inflammation, pain and swelling. RA affects an estimated 1.3 million Americans, about 1% of the population. Critical unmet needs in RA treatment are medications that effectively treat all people with RA, especially those who do not respond to disease-modifying antirheumatic drugs (DMARDs) or biologics.

RA involves a complex interplay between many different types of cells—including T cells, B cells, monocytes and fibroblasts—but the specific subtypes that drive disease progression are largely undefined. Understanding these cell types more precisely may hold valuable information in developing new treatments.

Continue reading “Researchers advance understandings of the cellular mechanisms driving rheumatoid arthritis” »